FAMOTIDINE INJECTION
As listed in the register: FAMOTIDINE INJECTION
10 mg · solution
- Prescription only
- Digestion, stomach, diabetes and nutrition
- Active substance
- Famotidine
- Made by
- Fresenius Kabi Canada Ltd
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (famotidine). It describes the substance, not this Bulgarian product — its uses and doses can differ.
Famotidine is a competitive inhibitor of histamine-2 (H 2 ) receptors.
The primary clinically important pharmacologic activity of famotidine is inhibition of gastric secretion.
Famotidine is eliminated by renal (65 to 70%) and metabolic (30 to 35%) routes.
Bioavailability may be slightly increased by food, or slightly decreased by antacids; however, these effects are of no clinical consequence.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2025-12-26
Safety of the active substance
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (famotidine). It describes the substance, not this Bulgarian product — its uses and doses can differ.
- Famotidine tablets are contraindicated in patients with a history of serious hypersensitivity reactions (e.g., anaphylaxis) to famotidine or other histamine-2 (H 2 ) receptor antagonists.
- History of serious hypersensitivity reactions (e.g., anaphylaxis) to famotidine or other H 2 receptor antagonists.
The most common adverse reactions are: headache, dizziness, constipation, and diarrhea.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
BulgariaNo exact match for this strength and form
SpainNo exact match for this strength and form
FranceNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Fresenius Kabi Canada Ltd |
|---|---|
| Active substance | Famotidine |
| Used in | Digestion, stomach, diabetes and nutrition |
| Strength | 10 mg |
| Form | solution |
| Classification | A02BA03 · Digestion, stomach, diabetes and nutrition |
| Route | intravenous |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Approved |
| Marketed | No — authorised but not currently marketed, according to the register |
| DIN | 02244133 |
| DPD drug code | 68093 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.